Delivery Order SPE2DB22D1106-SPE2DB25FFDH9
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,507.44 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Celecoxib 200 mg capsules in quantities of 500 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The award was issued from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a contract value of $6,610.43. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,503.49 for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, firm fixed price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a typical transactional purchase under the company's...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,786.34 for 100 capsules of Celebrex 200 mg on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Celebrex is a nonsteroidal anti-inflammatory drug commonly used for pain management and...
- The Defense Logistics Agency awarded a delivery order valued at $8,449.02 to AmerisourceBergen Drug Corp for 100 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Celebrex 200 mg capsules (100 count) with a contract value of $2,387.86. This firm fixed-price delivery order, which will be completed by August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.37 firm fixed-price delivery order is for the supply of Celecoxib 200 mg capsules, a medication used to treat pain and inflammation. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Celebrex 200 mg capsules (100-count units) with a ceiling value of $3,786.34. This competitive award employs firm fixed pricing under a delivery order contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, is for one hundred fifty-five dollars worth of Celecoxib 100 mg capsules. The order is for one hundred capsules and is a firm fixed price contract with performance taking place in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The completion date is September 12, 2023, approximately one year from the award date of September 11, 2023. As the Defense Logistics Agency is...